mRNA expression of PTEN and VEGF genes in epithelial ovarian cancer

Chinese Journal of Cancer Research

Volumn 15, Issue 4, 2003, Pages 252-256

  Chen, Ying ^a   Zhao, Yu Jie ^a   Zheng, Hua Chuan ^a   Yang, Xue Fei ^a   Wang, Gui Lan ^a   Xin, Yan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Carcinogenesis; Ovarian cancer; Progression; PTEN gene; VEGF gene

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; MUCINOUS CARCINOMA; OVARY CANCER; OVARY CYST; PROTEIN EXPRESSION; PROTEIN INDUCTION;

EID: 0347653788     PISSN: 10009604     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02974887     Document Type: Article

References (23)

1. Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers[J]. Nat Genet 1997; 15: 356.
2. Gu J, Tamura M, Yamada KM. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways[J]. J Cell Biol 1998; 143: 1375.
3. Tamura M, Gu J, Takino T, et al. Tumor suppressor PTEN inhibition of cell invasion, migration and growth: differential involvement of focal adhesion kinase and p130Cas[J]. Cancer Res 1999; 59: 442.
4. Jones G, Machado J Jr, Tolnay M, et al. PTEN-independent induction of caspase-mediated cell death and reduced invasion by the focal adhesion targeting domain (FAT) in human astrocytic brain tumors which highly express focal adhesion kinase (FAK)[J]. Cancer Res 2001; 61: 5688.
5. Gottschalk AR, Basila D, Wong M, et al. p27Kip1 is required for PTEN-induced G1 growth arrest[J]. Cancer Res 2001; 61: 2105.
6. Hopkin. K. A surprising function for the PTEN tumor suppressor[J]. Science 1998; 282: 1027.
7. Cantley LC, Neel BG. New insight into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway[J]. Proc Natl Acad Sci USA 1999; 96: 4240.
8. Huang J, Kontos CD. PTEN modulates vascular endothelial growth factor-Mediated signaling and angiogenic effects[J]. J Biol Chem 2002; 277: 10760.
9. Byzova TV, Goldman CK, Pampori N, et al. A mechanism for modulation of cellular responses to VEGF: activation of the integrins[J]. Mol Cell 2000; 6: 851.
10. Jiang BH, Zheng JZ, Aoki M, et al. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells[J]. Proc Natl Acad Sci USA 2000; 97: 1749.
11. Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis[J]. Am J Pathol 1995; 146: 1029.
12. Piccinno R, Puopolo M, Rigault De La Longrais IA, et al. Growth factors in epithelial ovarian cancer[J]. Minerva Ginecol 2002; 54: 33.
13. Bamberger ES, Perrett CW. Angiogenesis in epithelian ovarian cancer[J]. Mol Pathol 2002; 55: 348.
14. Witte L, Hicklin DJ, Zhu Z, et al. Monoclonal antibodies targeting the VEGF. receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy[J]. Cancer Metastasis Rev 1998; 17: 155.
15. Barnes MN, Grizzle WE, Grubbs CJ, et al. Paradigms for primary prevention of ovarian carcinoma[J]. CA Cancer J Clin 2002; 52: 216.
16. Waite KA, Eng C. Protean PTEN: form and function[J]. Am J Hum Genet 2002; 70: 829.
17. Kondo K, Yao M, Kobayashi K, et al. PTEN/MMAC1/TEP1 mutations in human primary renal-cell carcinomas and renal carcinoma cell lines[J]. Int J Cancer 2001; 91: 219.
18. Salvesen HB, MacDonald N, Ryan A, et al. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma[J]. Int J Cancer 2001; 91: 22.
19. Geva E, Jaffe RB. Role of vascular endothelial growth factor in ovarian physiology and pathology[J]. Fertil Steril 2000; 74: 429.
20. Sun LX, Wu Y, Han HQ, et al. Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma(in Chinese)[J]. Ai Zheng 2003; 22: 58.
21. Kurose K, Zhou XP, Araki T, et al. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas[J]. Am J Pathol 2001; 158: 2097.
22. Pore N, Liu S, Haas-Kogan DA, et al. PTEN mutation and epidermal growth factor receptor activation regulate vascular endothelial growth factor (VEGF) mRNA expression in human glioblastoma cells by transactivating the proximal VEGF promoter[J]. Cancer Res 2003; 63: 236.
23. Gomez-Manzano C, Fueyo J, Jiang H, et al. Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis[J]. Ann Neurol 2003; 53: 109.